Early Access Program
TheraRadar is currently free while we gather feedback from biotech professionals. Pricing will be introduced after the early access phase.
Early Access
Free
Access to all features during early access.
Includes:
- ✓ Drug intelligence pages
- ✓ Company profiles
- ✓ Target analysis
- ✓ Clinical trial pipelines
- ✓ Competitive landscapes
- ✓ Dashboards
Future Pro Plan
Designed for biotech investors, consultants, and analysts.
Features:
- ○ Full competitor landscapes
- ○ Advanced pipeline analytics
- ○ Trial timelines
- ○ Market intelligence dashboards
- ○ Exports and alerts
Price: Announced later
Early users will receive discounted access
Future Team Plan
Designed for biotech funds and pharma business development teams.
Features:
- ○ Multi-user access
- ○ Shared watchlists
- ○ Custom alerts
- ○ API access (future)
Price: Contact us
Notify me when Pro launches
TheraRadar Pro is coming soon.
Get early access and discounted pricing when subscriptions open.
No spam. Just launch updates.
Frequently Asked Questions
What data sources does TheraRadar use?
FDA Drugs@FDA for approvals, Orange Book for patents, ClinicalTrials.gov for trial data, SEC EDGAR for PDUFA dates and filings.
How often is the data updated?
Drug approvals, clinical trials, and PDUFA dates are updated weekly. Patent data is refreshed monthly.
How long will early access last?
We're gathering feedback from biotech professionals. Early access users will be notified before any pricing changes and will receive special discounts.